Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medicaid | 3 | 2025 | 143 | 0.950 |
Why?
|
| Prostatic Neoplasms | 9 | 2025 | 1092 | 0.850 |
Why?
|
| Surgical Procedures, Operative | 2 | 2017 | 33 | 0.820 |
Why?
|
| Hematuria | 1 | 2023 | 6 | 0.800 |
Why?
|
| Early Detection of Cancer | 5 | 2024 | 449 | 0.650 |
Why?
|
| Health Education | 3 | 2016 | 363 | 0.600 |
Why?
|
| Hospitals, Community | 1 | 2017 | 13 | 0.540 |
Why?
|
| Decision Support Techniques | 2 | 2021 | 49 | 0.530 |
Why?
|
| Physicians | 2 | 2017 | 188 | 0.480 |
Why?
|
| Prostate-Specific Antigen | 5 | 2024 | 147 | 0.400 |
Why?
|
| Primary Health Care | 2 | 2025 | 380 | 0.330 |
Why?
|
| Retrospective Studies | 8 | 2023 | 2544 | 0.320 |
Why?
|
| Health Facility Size | 1 | 2009 | 5 | 0.300 |
Why?
|
| Regional Health Planning | 1 | 2009 | 14 | 0.300 |
Why?
|
| Certification | 1 | 2009 | 21 | 0.290 |
Why?
|
| Wounds and Injuries | 1 | 2010 | 193 | 0.290 |
Why?
|
| Barbering | 3 | 2016 | 14 | 0.280 |
Why?
|
| Academic Medical Centers | 2 | 2021 | 76 | 0.280 |
Why?
|
| Social Class | 1 | 2010 | 291 | 0.280 |
Why?
|
| Health Status | 1 | 2010 | 442 | 0.250 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2006 | 8 | 0.250 |
Why?
|
| Health Services for the Aged | 1 | 2006 | 26 | 0.250 |
Why?
|
| Patient Participation | 2 | 2025 | 94 | 0.240 |
Why?
|
| Drug Prescriptions | 1 | 2006 | 60 | 0.240 |
Why?
|
| Remote Consultation | 1 | 2025 | 8 | 0.240 |
Why?
|
| Humans | 25 | 2025 | 43102 | 0.230 |
Why?
|
| Health Policy | 1 | 2006 | 184 | 0.220 |
Why?
|
| Medicare | 1 | 2006 | 332 | 0.200 |
Why?
|
| Patient Selection | 1 | 2025 | 205 | 0.200 |
Why?
|
| Clinical Trials as Topic | 1 | 2025 | 259 | 0.190 |
Why?
|
| Mathematics | 1 | 2003 | 57 | 0.190 |
Why?
|
| United States | 6 | 2025 | 5205 | 0.190 |
Why?
|
| Aged | 10 | 2024 | 8214 | 0.190 |
Why?
|
| Referral and Consultation | 1 | 2023 | 142 | 0.180 |
Why?
|
| Health Promotion | 3 | 2016 | 704 | 0.180 |
Why?
|
| Urology | 1 | 2021 | 9 | 0.170 |
Why?
|
| Body Weight | 1 | 2003 | 429 | 0.170 |
Why?
|
| Mass Screening | 3 | 2024 | 541 | 0.170 |
Why?
|
| Male | 16 | 2025 | 23409 | 0.160 |
Why?
|
| Healthcare Disparities | 4 | 2025 | 590 | 0.160 |
Why?
|
| Health Literacy | 1 | 2022 | 130 | 0.160 |
Why?
|
| Health Services Accessibility | 1 | 2025 | 706 | 0.160 |
Why?
|
| Decision Making | 2 | 2021 | 249 | 0.140 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2017 | 7 | 0.140 |
Why?
|
| Prostate | 2 | 2022 | 155 | 0.130 |
Why?
|
| Delivery of Health Care | 2 | 2017 | 310 | 0.130 |
Why?
|
| Middle Aged | 8 | 2024 | 12222 | 0.130 |
Why?
|
| Uncertainty | 1 | 2016 | 32 | 0.120 |
Why?
|
| Los Angeles | 1 | 2017 | 394 | 0.120 |
Why?
|
| California | 4 | 2025 | 548 | 0.120 |
Why?
|
| Adult | 6 | 2025 | 13872 | 0.110 |
Why?
|
| Vascular Surgical Procedures | 1 | 2013 | 18 | 0.100 |
Why?
|
| Lower Extremity | 1 | 2013 | 38 | 0.100 |
Why?
|
| Ischemia | 1 | 2013 | 47 | 0.100 |
Why?
|
| Managed Care Programs | 1 | 2013 | 40 | 0.100 |
Why?
|
| Fractures, Bone | 1 | 2011 | 63 | 0.090 |
Why?
|
| Budgets | 1 | 2011 | 15 | 0.090 |
Why?
|
| Child | 3 | 2011 | 3443 | 0.090 |
Why?
|
| Infant | 2 | 2011 | 1175 | 0.080 |
Why?
|
| Hospitalization | 2 | 2011 | 485 | 0.080 |
Why?
|
| Thoracic Surgery | 1 | 2009 | 1 | 0.080 |
Why?
|
| Hospitals, Veterans | 1 | 2009 | 15 | 0.080 |
Why?
|
| Medical Records | 1 | 2009 | 48 | 0.080 |
Why?
|
| General Surgery | 1 | 2009 | 28 | 0.080 |
Why?
|
| New York City | 1 | 2010 | 288 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2011 | 1546 | 0.080 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 55 | 0.080 |
Why?
|
| Community Networks | 1 | 2010 | 107 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 989 | 0.070 |
Why?
|
| Data Collection | 1 | 2009 | 210 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 719 | 0.070 |
Why?
|
| Residence Characteristics | 1 | 2010 | 363 | 0.070 |
Why?
|
| Cost Savings | 1 | 2006 | 18 | 0.060 |
Why?
|
| Social Change | 1 | 2006 | 19 | 0.060 |
Why?
|
| Social Support | 1 | 2010 | 445 | 0.060 |
Why?
|
| Dermatology | 1 | 2025 | 3 | 0.060 |
Why?
|
| Insurance Coverage | 1 | 2006 | 110 | 0.060 |
Why?
|
| Specialization | 1 | 2025 | 26 | 0.060 |
Why?
|
| Risk Factors | 2 | 2011 | 3994 | 0.060 |
Why?
|
| Papilloma | 1 | 2004 | 17 | 0.060 |
Why?
|
| Female | 6 | 2025 | 24698 | 0.050 |
Why?
|
| Calorimetry | 1 | 2003 | 20 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 749 | 0.050 |
Why?
|
| Glomerular Mesangium | 1 | 2002 | 5 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2024 | 223 | 0.050 |
Why?
|
| Young Adult | 2 | 2011 | 5080 | 0.050 |
Why?
|
| Oxidants | 1 | 2002 | 42 | 0.050 |
Why?
|
| Adolescent | 2 | 2011 | 6081 | 0.050 |
Why?
|
| Comprehension | 1 | 2022 | 41 | 0.050 |
Why?
|
| Weight Loss | 1 | 2003 | 137 | 0.050 |
Why?
|
| Survivors | 1 | 2022 | 152 | 0.040 |
Why?
|
| Reference Values | 2 | 2011 | 211 | 0.040 |
Why?
|
| Glucose | 1 | 2002 | 244 | 0.040 |
Why?
|
| Curriculum | 1 | 2003 | 318 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 611 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 1067 | 0.040 |
Why?
|
| Incidence | 2 | 2013 | 1078 | 0.040 |
Why?
|
| Age Factors | 2 | 2012 | 1154 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 2853 | 0.030 |
Why?
|
| Apoptosis | 1 | 2002 | 1568 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2004 | 1723 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2013 | 95 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 159 | 0.020 |
Why?
|
| Biopsy | 1 | 2013 | 177 | 0.020 |
Why?
|
| Markov Chains | 1 | 2011 | 43 | 0.020 |
Why?
|
| New York | 1 | 2011 | 93 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2011 | 75 | 0.020 |
Why?
|
| Models, Economic | 1 | 2011 | 28 | 0.020 |
Why?
|
| Age Distribution | 1 | 2011 | 249 | 0.020 |
Why?
|
| Probability | 1 | 2011 | 82 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2011 | 179 | 0.020 |
Why?
|
| Logistic Models | 1 | 2013 | 1009 | 0.020 |
Why?
|
| Prognosis | 1 | 2013 | 861 | 0.020 |
Why?
|
| Medical Audit | 1 | 2009 | 26 | 0.020 |
Why?
|
| Benchmarking | 1 | 2009 | 32 | 0.020 |
Why?
|
| Policy Making | 1 | 2009 | 35 | 0.020 |
Why?
|
| Program Development | 1 | 2010 | 240 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2011 | 408 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2011 | 972 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2009 | 359 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 1612 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 1081 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 59 | 0.010 |
Why?
|
| Radiography | 1 | 2004 | 71 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 2002 | 14 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2002 | 76 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 77 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2002 | 181 | 0.010 |
Why?
|
| Caspases | 1 | 2002 | 148 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 152 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 257 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2002 | 358 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2002 | 532 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 1124 | 0.010 |
Why?
|
| Cell Survival | 1 | 2002 | 945 | 0.010 |
Why?
|
| Cell Line | 1 | 2002 | 1410 | 0.010 |
Why?
|
| Mice | 1 | 2002 | 6644 | 0.010 |
Why?
|
| Animals | 1 | 2002 | 16992 | 0.000 |
Why?
|